Skip to main content

Universal Health Services income statement

  • UHS · NYSE
  • Healthcare
  • Health Care Facilities
  • S&P 500
$194.07+0.12%Close 13 Nov 2026

Universal Health Services reported revenue of $17.4 billion for fiscal year 2025 (the twelve months to 31 Dec 2025), up 9.7% from fiscal 2024. Net income was $1.49 billion and diluted earnings per share $23.10.

From Universal Health Services's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025. TTM is the last four reported quarters added up.

Annual

Universal Health Services income statement, annual
USDFY 2008FY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Revenue$5.02B$5.20B$4.90B$6.76B$6.96B$7.37B$8.21B$9.04B$9.77B$10.41B$10.77B$11.38B$11.56B$12.64B$13.40B$14.28B$15.83B$17.36B$18.35B
Revenue growth—+3.6%−5.8%+38.0%+3.0%+5.8%+11.4%+10.2%+8.0%+6.6%+3.5%+5.6%+1.6%+9.4%+6.0%+6.6%+10.8%+9.7%—
Net interest income—$0.00$0.00$0.00$0.00$0.00$0.00$0.00———————————
Operating expenses$4.61B$4.68B$4.39B$5.86B$6.02B$6.35B$7.14B$7.78B$8.48B$9.13B$9.60B$10.16B$10.20B$11.28B$12.40B$13.11B$14.15B$15.37B$16.36B
Operating income$410.2M$520.5M$505.7M$897.1M$942.6M$1.02B$1.06B$1.26B$1.28B$1.28B$1.18B$1.22B$1.36B$1.36B$1.00B$1.18B$1.68B$1.99B$1.99B
Operating margin8.2%10.0%10.3%13.3%13.5%13.8%13.0%13.9%13.1%12.3%10.9%10.7%11.8%10.8%7.5%8.2%10.6%11.5%10.8%
Interest expense$53.21M$45.81M$77.62M$200.8M$178.9M$146.1M$133.6M$113.5M$125.1M$145.2M$155.0M$162.7M$106.3M$83.67M$126.9M$206.7M$186.1M$156.1M$175.5M
Income before tax$357.0M$474.7M$428.1M$696.3M$763.7M$869.3M$929.7M$1.15B$1.16B$1.14B$1.03B$1.07B$1.25B$1.29B$866.3M$940.4M$1.50B$1.97B$1.94B
Income tax expense$123.4M$170.5M$152.3M$247.5M$274.6M$315.3M$324.7M$395.2M$409.2M$363.7M$236.6M$238.8M$299.3M$305.7M$209.3M$221.1M$334.8M$461.0M$459.2M
Effective tax rate34.6%35.9%35.6%35.5%36.0%36.3%34.9%34.5%35.4%32.0%22.9%22.4%23.9%23.6%24.2%23.5%22.4%23.4%23.6%
Net income$199.4M$260.4M$230.2M$398.2M$443.4M$510.7M$545.3M$680.5M$702.4M$752.3M$779.7M$814.9M$944.0M$991.6M$675.6M$717.8M$1.14B$1.49B$1.46B
Net margin4.0%5.0%4.7%5.9%6.4%6.9%6.6%7.5%7.2%7.2%7.2%7.2%8.2%7.8%5.0%5.0%7.2%8.6%8.0%
Net income to common shareholders—————————————$989.5M$674.9M$717.5M$1.14B$1.49B$1.46B
EPS · diluted$1.96$2.64$2.34$4.04$4.53$5.14$5.42$6.76$7.14$7.81$8.31$9.13$10.99$11.82$9.14$10.23$16.82$23.10$23.97
Diluted weighted average shares101M98.3M98.0M98.5M97.7M99.4M101M101M98.4M96.3M93.8M89.0M85.6M83.7M73.8M70.1M67.9M64.5M61.0M
Basic weighted average shares101M97.8M96.8M97.2M96.8M98.0M98.8M98.8M97.2M95.7M93.3M88.8M85.1M82.5M73.1M69.3M66.6M63.6M60.4M
EBITDA$606.0M$725.2M$729.7M$1.19B$1.25B$1.35B$1.44B$1.66B$1.70B$1.73B$1.63B$1.71B$1.87B$1.90B$1.59B$1.74B$2.27B$2.61B$2.65B
EBITDA margin12.1%13.9%14.9%17.6%18.0%18.4%17.5%18.3%17.4%16.6%15.1%15.0%16.2%15.0%11.8%12.2%14.3%15.0%14.5%
Depreciation & amortization$195.8M$204.7M$224.0M$295.9M$308.7M$337.4M$375.6M$398.6M$416.6M$447.8M$453.0M$490.4M$510.5M$533.2M$581.9M$568.0M$584.8M$618.7M$660.9M
Stock-based compensation$14.13M$13.10M$16.80M$18.23M$22.52M$27.78M$31.09M$39.97M$48.11M$56.74M$66.58M$69.43M$65.84M$73.69M$85.38M$87.72M$99.35M$95.69M$96.88M
Dividends per share—$0.17$0.20$0.20$0.60$0.20$0.30———$0.40$0.60—$0.80$0.80$0.80$0.80$0.80$0.80

Quarterly

Universal Health Services income statement, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Revenue$3.70B$3.84B$3.91B$3.96B$4.11B$4.10B$4.28B$4.50B$4.49B$4.50B$4.64B$4.73B
Operating expenses$3.37B$3.45B$3.47B$3.58B$3.64B$3.64B$3.78B$3.97B$3.97B$3.99B$4.12B$4.28B
Operating income$331.2M$388.8M$436.4M$384.2M$472.5M$454.8M$500.3M$521.7M$517.2M$502.9M$516.7M$454.4M
Operating margin8.9%10.1%11.2%9.7%11.5%11.1%11.7%11.6%11.5%11.2%11.1%9.6%
Interest expense$53.59M$52.83M$48.90M$44.66M$39.72M$40.06M$35.36M$38.43M$42.22M$37.13M$39.91M$56.28M
Income before tax$281.1M$336.1M$382.0M$341.5M$438.3M$420.4M$473.4M$496.9M$581.4M$469.1M$479.1M$413.9M
Income tax expense$61.50M$70.26M$87.68M$75.62M$101.3M$98.80M$110.8M$117.8M$133.6M$110.4M$114.5M$100.6M
Effective tax rate21.9%20.9%23.0%22.1%23.1%23.5%23.4%23.7%23.0%23.5%23.9%24.3%
Net income$216.4M$261.8M$289.2M$258.7M$332.4M$316.7M$353.2M$373.0M$445.9M$348.7M$358.4M$308.7M
Net margin5.8%6.8%7.4%6.5%8.1%7.7%8.2%8.3%9.9%7.8%7.7%6.5%
Net income to common shareholders$216.3M$261.8M—$258.7M$332.4M$316.7M$353.2M$373.0M$445.9M$348.7M$358.4M$308.7M
EPS · diluted$3.15$3.82$4.26$3.80$4.96$4.80$5.43$5.86$7.06$5.65$5.98$5.22
Diluted weighted average shares68.6M68.5M67.9M68.1M67.1M66.0M65.0M63.7M63.2M61.7M59.9M59.1M
Basic weighted average shares67.8M67.2M66.9M66.5M65.6M65.0M64.4M63.0M62.0M61.1M59.7M58.8M
EBITDA$476.7M$529.8M$583.9M$533.7M$619.3M$603.2M$652.3M$676.7M$680.6M$658.3M$684.0M$629.3M
EBITDA margin12.9%13.8%14.9%13.5%15.1%14.7%15.2%15.1%15.2%14.6%14.7%13.3%
Depreciation & amortization$145.5M$141.0M$147.5M$149.6M$146.8M$148.3M$152.0M$155.1M$163.3M$155.4M$167.3M$174.8M
Stock-based compensation$22.02M$19.63M$26.53M$26.57M$26.62M$21.59M$24.11M$24.88M$25.10M$22.50M$22.91M$26.36M
Dividends per share$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20

The main figures as JSON and plain text. See data and methodology.

UHS in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.